BRIEF published on 08/20/2025 at 23:35, 9 months 8 days ago Medicure Reports Q2 2025 Financial Results Financial Results Net Loss Net Revenue Research Investment Pharmaceutical Business
PRESS RELEASE published on 08/20/2025 at 23:30, 9 months 8 days ago Medicure Reports Financial Results for Quarter Ended June 30, 2025 Medicure Inc. reports Q2 2025 financial results, including increased revenue from Marley Drug and ZYPITAMAG(R), and enhanced adjusted EBITDA. Find full details at www.medicure.com Financial Results Medicure Inc. Marley Drug ZYPITAMAG Q2 2025
BRIEF published on 08/18/2025 at 23:35, 9 months 10 days ago Medicure to Announce Q2 2025 Financial Results via Conference Call Financial Results Conference Call Pharmaceuticals Medicure Q2 2025
PRESS RELEASE published on 08/18/2025 at 23:30, 9 months 10 days ago Medicure to Present Financial Results on August 21, 2025 Call at 8:30 am ET for Quarter Ended June 30, 2025 Medicure Inc. to present Financial Results for Q2 2025 on August 21, 2025 via conference call. Operations and products focus detailed Financial Results Conference Call Pharmaceuticals Medicure Inc. Healthcare Products
BRIEF published on 06/17/2025 at 23:05, 11 months 11 days ago Medicure Finalizes Acquisition of West Olympia Pharmacy Acquisition Revenue Growth Pharmaceuticals Pharmacy Medicure
PRESS RELEASE published on 06/17/2025 at 23:00, 11 months 11 days ago Medicure Announces Closing of Purchase Agreement for The Acquisition of West Olympia Pharmacy Medicure Inc. announces acquisition of West Olympia Pharmacy Inc., further boosting direct-to-consumer pharmacy business and sales of ZYPITAMAG(R) and BRENZAVVY(R) Acquisition Medicure Inc. Pharmacy Business ZYPITAMAG(R) BRENZAVVY(R)
BRIEF published on 05/21/2025 at 23:05, 1 year ago Medicure Announces Q1 2025 Financial Results and Director Election Outcomes Net Loss Director Election Medicure Financial Results AGGRASTAT Sales Decline Pharmacy Revenue
PRESS RELEASE published on 05/21/2025 at 23:00, 1 year ago Medicure Reports Financial Results for Quarter Ended March 31, 2025 and Annual General Meeting Director Election Results Medicure Inc. reports Q1 2025 results with $5.5M net revenue, elects directors, and details financial performance. AGGRASTAT and ZYPITAMAG sales analyzed Medicure Inc. Net Revenue AGGRASTAT ZYPITAMAG Q1 2025 Results
BRIEF published on 04/25/2025 at 23:06, 1 year 1 month ago Medicure Inc. Reveals Financial Results for 2024 Medicure Inc. 2024 AGGRASTAT® Sales ZYPITAMAG® Revenue Marley Drug Financials Adjusted EBITDA Decline
PRESS RELEASE published on 04/25/2025 at 23:01, 1 year 1 month ago Medicure Reports Financial Results for Quarter and Year Ended December 31, 2024 Medicure Inc. reports total net revenue of $21.9 million for year ended Dec 31, 2024. AGGRASTAT & Marley Drug sales increase, while Adjusted EBITDA declines Adjusted EBITDA Medicure Inc. Marley Drug Net Revenue AGGRASTAT
Published on 05/28/2026 at 23:40, 12 minutes ago Power Metallic Mines Announces Brokered LIFE Offering for Gross Proceeds of up to C$25 Million
Published on 05/28/2026 at 23:30, 22 minutes ago IBC Advanced Alloys Announces Amendment to Existing Term Loan
Published on 05/28/2026 at 23:25, 27 minutes ago 55 North Mining Inc. Appoints Michael Thompson, P.Geo., as VP of Exploration
Published on 05/28/2026 at 22:35, 1 hour 17 minutes ago Pinetree Capital Announces Election of Directors
Published on 05/28/2026 at 19:20, 4 hours 32 minutes ago Lithium South Announces Filing of Audited Financial Statements, Receipt of Revocation Order, Closing of Plan of Arrangement and Delisting from TSX Venture Exchange
Published on 05/28/2026 at 22:54, 58 minutes ago Vulcan's funding package for Lionheart reaches Financial Close
Published on 05/28/2026 at 22:15, 1 hour 37 minutes ago Nebius to present at BofA Global Technology conference
Published on 05/28/2026 at 19:23, 4 hours 29 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/28/2026 at 18:50, 5 hours 2 minutes ago Menarini Group Presents New Data from the Phase 1b/2 ELEVATE Study of Elacestrant in Combination with Capivasertib in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
Published on 05/28/2026 at 18:34, 5 hours 18 minutes ago LNA SANTE : Expanding hospital at home in Ile-de-France region
Published on 05/28/2026 at 18:06, 5 hours 45 minutes ago Net profit and EBITDA up driven by the recovery in volumes and improvement in unit margins in the Recycling business. Upgrade in outlook
Published on 05/28/2026 at 17:50, 6 hours 2 minutes ago Press release relating to the availability of the preparatory documents – GM of 18 June 2026
Published on 05/28/2026 at 17:45, 6 hours 7 minutes ago EURAZEO ACQUIRES T1A GROUP IN DENMARK TO ACCELERATE THE CIRCULAR ECONOMY IN THE IT SECTOR
